Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.

Saved in:
Bibliographic Details
Title: Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
Authors: Engelhard M; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany., Wingen-Heimann SM; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Faculty of Medicine), University Hospital Cologne, University of Cologne, Cologne, Germany.; University of Applied Sciences for Economics and Management (FOM), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Classen AY; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Blau IW; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Bug G; Department of Medicine 2, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Hebermehl C; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany., Kraus S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Penack O; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany., Rettig AR; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany., Schmitt T; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany., Steinbrunn T; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Teschner D; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany., Wehr C; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany., Vehreschild JJ; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany., Pütz SM; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany. sina.puetz@uk-koeln.de.
Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2026 Feb 16. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41692914
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Engelhard+M%22">Engelhard M</searchLink>; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wingen-Heimann+SM%22">Wingen-Heimann SM</searchLink>; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Faculty of Medicine), University Hospital Cologne, University of Cologne, Cologne, Germany.; University of Applied Sciences for Economics and Management (FOM), Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Classen+AY%22">Classen AY</searchLink>; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Blau+IW%22">Blau IW</searchLink>; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bug+G%22">Bug G</searchLink>; Department of Medicine 2, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Hebermehl+C%22">Hebermehl C</searchLink>; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Kraus+S%22">Kraus S</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Penack+O%22">Penack O</searchLink>; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Rettig+AR%22">Rettig AR</searchLink>; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+T%22">Schmitt T</searchLink>; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Steinbrunn+T%22">Steinbrunn T</searchLink>; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Teschner+D%22">Teschner D</searchLink>; Department of Hematology and Medical Oncology, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Vehreschild+MJGT%22">Vehreschild MJGT</searchLink>; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wehr+C%22">Wehr C</searchLink>; Department of Medicine I/Hematology, Oncology and Stem Cell Transplantation, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Vehreschild+JJ%22">Vehreschild JJ</searchLink>; Faculty of Medicine, Department I of Internal Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Faculty of Medicine, Goethe University Frankfurt, Institute for Digital Medicine and Clinical Data Science, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Pütz+SM%22">Pütz SM</searchLink>; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany. sina.puetz@uk-koeln.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101134867%22">The European journal of health economics : HEPAC : health economics in prevention and care</searchLink> [Eur J Health Econ] 2026 Feb 16. <i>Date of Electronic Publication: </i>2026 Feb 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101134867 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1618-7601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216187598%22">16187598 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Health Econ <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41692914
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10198-025-01890-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Engelhard M
      – PersonEntity:
          Name:
            NameFull: Wingen-Heimann SM
      – PersonEntity:
          Name:
            NameFull: Classen AY
      – PersonEntity:
          Name:
            NameFull: Blau IW
      – PersonEntity:
          Name:
            NameFull: Bug G
      – PersonEntity:
          Name:
            NameFull: Hebermehl C
      – PersonEntity:
          Name:
            NameFull: Kraus S
      – PersonEntity:
          Name:
            NameFull: Penack O
      – PersonEntity:
          Name:
            NameFull: Rettig AR
      – PersonEntity:
          Name:
            NameFull: Schmitt T
      – PersonEntity:
          Name:
            NameFull: Steinbrunn T
      – PersonEntity:
          Name:
            NameFull: Teschner D
      – PersonEntity:
          Name:
            NameFull: Vehreschild MJGT
      – PersonEntity:
          Name:
            NameFull: Wehr C
      – PersonEntity:
          Name:
            NameFull: Vehreschild JJ
      – PersonEntity:
          Name:
            NameFull: Pütz SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2026 Feb 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1618-7601
          Titles:
            – TitleFull: The European journal of health economics : HEPAC : health economics in prevention and care
              Type: main
ResultId 1